Table 3 Statistical correlation of anti-NMDAR antibody with parameters obtained from clinical rating scales in the patient group of the study
Parameter | NMDA | Test of significance | ||||
|---|---|---|---|---|---|---|
Negative | Positive | |||||
Mean ± SD | Mean ± SD | Value | p-value | Sig. | ||
N (%) | N (%) | |||||
ADOS level of Autism related symptoms | Mild | 4 (6.25%) | 3 (13.04%) | X2 = 3.786 | 0.151(C) | NS |
Moderate | 29 (45.31%) | 14 (60.87%) | ||||
High | 31 (48.44%) | 6 (26.09%) | ||||
Probability to diagnose ASD in GARS | 87 (65–89) | 35 (19–84) | U = 414.5 | 0.002(M) | S | |
Stereotyped behavior most affected | Sensory | 30 (46.88%) | 12 (52.17%) | X2= 4.621 | 0.099(C) | NS |
Verbal | 27 (42.19%) | 5 (21.74%) | ||||
Motor | 7 (10.94%) | 6 (26.09%) | ||||
Stereotyped behavior degree | Low | 32 (50%) | 12 (52.17%) | < 0.001(F) | S | |
Below average | 32 (50%) | 5 (21.74%) | ||||
Average | 0 (0%) | 6 (26.09%) | ||||
Vineland’s domain most affected | Communication | 21 (32.81%) | 8 (34.78%) | 0.474(F) | NS | |
Daily life | 0 (0%) | 0 (0%) | ||||
Social | 19 (29.69%) | 7 (30.43%) | ||||
Motor | 0 (0%) | 1 (4.35%) | ||||
Communication + Social | 24 (37.5%) | 7 (30.43%) | ||||
Total calibrated score of Vinland Adaptive Behavior Scale | 31 (26–31) | 45 (39–51) | U = 247.0 | < 0.001(M) | S | |
Age coefficient | 0.16 (0.13–0.27) | 0.28 (0.2–0.4) | U = 365.5 | < 0.001(M) | S | |